SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Cell Genesys (CEGE) -- Ignore unavailable to you. Want to Upgrade?

To: Tom Hua who wrote (683)2/17/2000 11:09:00 AM
From: sam  Respond to of 1298
 
I'm actually surprised that in this biotech friendly market, CEGE hasn't run to 50 quite yet. It'll probably run even higher than that. 70? Biotechs should remain strong through the year as funds are just now beginning to take the positions they've been neglecting for the last 5 years.



To: Tom Hua who wrote (683)2/17/2000 11:17:00 AM
From: Steven Osborne  Read Replies (2) | Respond to of 1298
 
Tom,
I sold 25%@34, holding the last 25% for your 50 target.
This is incredible. CEGE has been posting good medical news for 3 years. Now we pop.
Steve


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News